The Independent Voice of
European Private Equity

Advanced Search

Gilde Healthcare sells Viroclinics Biosciences to Parcom Capital

Luciano Figari 29 August 2017

Gilde Healthcare has sold virology contract research organisation (CRO) Viroclinics Biosciences to Netherlands-based mid-market private equity firm Parcom

Next article »

« Previous article

Related Articles

VC performance hits new high

23/07/19

Waterland-backed Median makes two deals

23/07/19

LBO France makes investment in Ecritel

23/07/19

Agilitas-backed Hydro makes second bolt-on

23/07/19

Innova Capital buys Optiplaza

23/07/19

Maven invests in computing company ebb3

23/07/19